Reasons for Prehospital Delay in Patients With Acute Ischemic Stroke


Phase N/A Results N/A

Summary of Purpose

Ischemic stroke is the leading cause of acquired disability among adults, and one of the main causes of death. In Switzerland, the approved time window for stroke treatment with intravenous thrombolysis after symptom onset is 4.5 h. Even within the 4.5 h time-window, however, the benefit of treatment strongly decreases as time passes. Moreover, only around 10% patients receive thrombolytic treatment, since...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 December 2017.

1 Aug 2015 2 Jun 2016 1 Sep 2018 1 Sep 2018 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample